-+ 0.00%
-+ 0.00%
-+ 0.00%

Estrella Immunopharma Q3 EPS $(0.17) Misses $(0.08) Estimate

Benzinga·11/16/2026 12:25:11
Estrella Immunopharma (NASDAQ:ESLA) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.08) by 112.5 percent. This is a 30.77 percent decrease over losses of $(0.13) per share from the same period last year.